全文获取类型
收费全文 | 743篇 |
免费 | 36篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 19篇 |
妇产科学 | 21篇 |
基础医学 | 75篇 |
口腔科学 | 22篇 |
临床医学 | 84篇 |
内科学 | 162篇 |
皮肤病学 | 15篇 |
神经病学 | 69篇 |
特种医学 | 19篇 |
外科学 | 94篇 |
综合类 | 11篇 |
一般理论 | 1篇 |
预防医学 | 75篇 |
眼科学 | 12篇 |
药学 | 65篇 |
中国医学 | 6篇 |
肿瘤学 | 19篇 |
出版年
2024年 | 1篇 |
2023年 | 8篇 |
2022年 | 34篇 |
2021年 | 55篇 |
2020年 | 38篇 |
2019年 | 42篇 |
2018年 | 39篇 |
2017年 | 33篇 |
2016年 | 31篇 |
2015年 | 29篇 |
2014年 | 45篇 |
2013年 | 54篇 |
2012年 | 63篇 |
2011年 | 72篇 |
2010年 | 34篇 |
2009年 | 14篇 |
2008年 | 32篇 |
2007年 | 31篇 |
2006年 | 17篇 |
2005年 | 21篇 |
2004年 | 20篇 |
2003年 | 17篇 |
2002年 | 12篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 3篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1982年 | 1篇 |
1979年 | 2篇 |
1977年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 2篇 |
1955年 | 1篇 |
排序方式: 共有783条查询结果,搜索用时 140 毫秒
61.
eEF1A2 (eukaryotic protein elongation factor 1 alpha 2) is a protein translation factor that is likely a human oncogene by virtue of its capacity to transform mammalian cells and its high expression in tumors of the ovary, breast and lung. Here, we show that expression of eEF1A2 is sufficient to stimulate the formation of filopodia in BT549 human breast cancer cells and non-transformed Rat2 cells. Filopodia formation in eEF1A2-expressing cells is dependent on the activity of phosphatidylinositol-3 kinase (PI3K), and the ROCK and Akt kinases. Furthermore, eEF1A2 expression is sufficient to activate Akt in a PI3K-dependent fashion and inactivation of eEF1A2 by short interfering RNA reduces Akt activity. Using breast cancer cell line BT 549, we show that eEF1A2 expression stimulates cell migration and invasion in a largely PI3K- and Akt-dependent manner. These results suggest that eEF1A2 regulates oncogenesis through Akt and PI3K-dependent cytoskeletal remodeling. 相似文献
62.
63.
Aggression is common in Huntington's disease. However, at present there are no standard guidelines for managing aggression in Huntington's sufferers due to a lack of empirical research. This paper presents a case study of the treatment of very high levels of aggression with sensory modulation and behaviour support intervention in a Huntington's sufferer. The client exhibited a range of aggressive behaviours, including physical aggression to people, furniture and objects, and verbal aggression. Following an eight week baseline phase, five weeks of sensory modulation intervention were employed. A behaviour support plan was then implemented as an adjunct to the sensory intervention, with aggressive behaviour systematically audited for a further 11 weeks. The results indicate a significant reduction in reported levels of aggression during the combined sensory modulation and behaviour support phase, compared to both the baseline and the sensory modulation therapy alone phases. This case study highlights the efficacy non-pharmacological interventions may have for reducing aggression in HD. 相似文献
64.
65.
66.
Seroprevalence,molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors
下载免费PDF全文
![点击此处可从《Journal of medical virology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
67.
Germaine Korner Tanja Scherer Dea Adamsen Alexander Rebuffat Mark Crabtree Anahita Rassi Rossana Scavelli Daigo Homma Birgit Ledermann Daniel Konrad Hiroshi Ichinose Christian Wolfrum Marion Horsch Birgit Rathkolb Martin Klingenspor Johannes Beckers Eckhard Wolf Valérie Gailus-Durner Helmut Fuchs Martin Hrabě de Angelis Nenad Blau Jan Rozman Beat Thöny 《Journal of inherited metabolic disease》2016,39(2):309-319
68.
Pierre Pradat Victor Virlogeux Marianne Maynard Mathilde Leclercq Giorgiana Hatu Majid Amiri Fanny Lebosse Patrick Miailhes Fabien Zoulim Marie-Claude Gagnieu Fran?ois Bailly 《Hepatitis monthly》2015,15(9)
Background:
Anemia is more frequent in patients receiving telaprevir with PEGylated interferon/ribavirin (PEG-IFN/RBV) than in those receiving PEG-IFN/RBV alone.Objectives:
The objective was to measure the impact of telaprevir on RBV bioavailability and to assess the concomitant renal function.Materials and Methods:
Thirty-seven hepatitis C virus (HCV) patients non-responders to a previous course of PEG-IFN/RBV therapy and re-treated with triple therapy combining PEG-IFN/RBV and telaprevir were analyzed. RBV bioavailability was measured before the triple therapy initiation, during telaprevir treatment at week (W) 4 and W8, and after telaprevir cessation (post W16). The renal function was assessed by estimating the glomerular filtration rate (eGFR).Results:
At W4, RBV bioavailability, expressed as mg/L/daily dose/kg body weight, was significantly increased (median increase = 0.06 mg/L/dose/kg; P < 0.001). In parallel, the renal function was impaired with a mean eGFR decrease of -6.8 mL/minutes/1.73 m² (P = 0.109). Between W4 and W8, RBV bioavailability continued to increase (P < 0.001) but subsequently decreased slightly after telaprevir discontinuation with a concomitant restoration of the renal function (eGFR increase of 6.34 mL/minutes/1.73 m²).Conclusions:
Our results indicated a reversible increase in RBV bioavailability after telaprevir exposure, which might be linked to the impairment of the GFR. This also suggests a RBV-telaprevir pharmacological interaction, a possible source of severe anemia observed under triple therapy. These results suggest that RBV pharmacological monitoring may be clinically relevant, especially in the context of first-generation HCV protease inhibitor-based therapy. 相似文献69.
Vahid Sharifi Ali Abbasi Anahita Nosrati 《Yao wu shi pin fen xi = Journal of food and drug analysis.》2016,24(2):264
The recent developments in hollow fiber liquid phase microextraction and dispersive liquid –liquid microextraction are reviewed. Applications of these newly emerging developments in extraction and preconcentration of a vast category of compounds including heavy metals, pesticides, pharmaceuticals and abused drugs in complex matrices (environmental and biological matrices) are reviewed and discussed. The new developments in these techniques including the use of solvents lighter than water, ionic liquids and supramolecular solvents are also considered. Applications of these new solvents reduce the use of toxic solvents and eliminate the centrifugation step, which reduces the extraction time. 相似文献
70.